Cargando…

Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and COVID-19-related outcomes: A patient-level analysis of the PCORnet blood pressure control lab

SARS-CoV-2 accesses host cells via angiotensin-converting enzyme-2, which is also affected by commonly used angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), raising concerns that ACEI or ARB exposure may portend differential COVID-19 outcomes. In parallel co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Steven M., Desai, Raj A., Walsh, Marta G., Nilles, Ester Kim, Shaw, Katie, Smith, Myra, Chamberlain, Alanna M., Derington, Catherine G., Bress, Adam P., Chuang, Cynthia H., Ford, Daniel E., Taylor, Bradley W., Chandaka, Sravani, Patel, Lav Parshottambhai, McClay, James, Priest, Elisa, Fuloria, Jyotsna, Doshi, Kruti, Ahmad, Faraz S., Viera, Anthony J., Faulkner, Madelaine, O'Brien, Emily C., Pletcher, Mark J., Cooper-DeHoff, Rhonda M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Inc. 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889730/ https://www.ncbi.nlm.nih.gov/pubmed/35252907 http://dx.doi.org/10.1016/j.ahjo.2022.100112

Ejemplares similares

Disruption in Blood Pressure Control With the COVID-19 Pandemic: The PCORnet Blood Pressure Control Laboratory
por: Chamberlain, Alanna M., et al.
Publicado: (2023)

Tracking Blood Pressure Control Performance and Process Metrics in 25 US Health Systems: The PCORnet Blood Pressure Control Laboratory
por: Cooper‐DeHoff, Rhonda M., et al.
Publicado: (2021)

PCORnet’s Collaborative Research Groups
por: Pletcher, Mark J, et al.
Publicado: (2018)

Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans
por: Derington, Catherine G., et al.
Publicado: (2021)

Engagement in PCORnet Research Networks
por: Kim, Katherine K., et al.
Publicado: (2018)

New Users of Angiotensin II Receptor Blocker–Versus Angiotensin‐Converting Enzyme Inhibitor–Based Antihypertensive Medication Regimens and Cardiovascular Disease Events: A Secondary Analysis of ACCORD‐BP and SPRINT
por: King, Jordan B., et al.
Publicado: (2023)

PCORnet: turning a dream into reality
por: Collins, Francis S, et al.
Publicado: (2014)

Comparing Prescribing and Dispensing Data of the PCORnet Common Data Model Within PCORnet Antibiotics and Childhood Growth Study
por: Lin, Pi-I D., et al.
Publicado: (2019)

Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT)
por: Cohen, Jordana B., et al.
Publicado: (2022)

Relationship Between ACE2 and Other Components of the Renin-Angiotensin System
por: Cohen, Jordana B., et al.
Publicado: (2020)

Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment
por: Marcum, Zachary A., et al.
Publicado: (2022)

What’s new in the renin-angiotensin system?: What’s new in the renin-angiotensin system?
por: Smith, A. I., et al.
Publicado: (2004)

PCORnet® 2020: current state, accomplishments, and future directions
por: Forrest, Christopher B., et al.
Publicado: (2021)

Avenues for Strengthening PCORnet’s Capacity to Advance Patient-Centered Economic Outcomes in Patient-Centered Outcomes Research (PCOR)
por: Waitman, Lemuel R., et al.
Publicado: (2023)

Developing an ETL tool for converting the PCORnet CDM into the OMOP CDM to facilitate the COVID-19 data integration
por: Yu, Yue, et al.
Publicado: (2022)

The National Patient-Centered Clinical Research Network (PCORnet) Bariatric Study Cohort: Rationale, Methods, and Baseline Characteristics
por: Toh, Sengwee, et al.
Publicado: (2017)

Launching PCORnet, a national patient-centered clinical research network
por: Fleurence, Rachael L, et al.
Publicado: (2014)

The Greater Plains Collaborative: a PCORnet Clinical Research Data Network
por: Waitman, Lemuel R, et al.
Publicado: (2014)

Multistakeholder Engagement in PCORnet, the National Patient-Centered Clinical Research Network
por: Selby, Joe V., et al.
Publicado: (2018)

Comparative effectiveness of bariatric procedures among adolescents: the PCORnet bariatric study
por: Inge, Thomas H., et al.
Publicado: (2018)

Angiotensin-(1-7), Angiotensin-Converting Enzyme 2, and New Components of the Renin Angiotensin System
por: Trask, Aaron J., et al.
Publicado: (2009)

What’s new in the renin-angiotensin system?: Angiotensin-converting enzyme-2: a molecular and cellular perspective
por: Warner, F. J., et al.
Publicado: (2004)

Preoperative Depression Status and 5 Year Metabolic and Bariatric Surgery Outcomes in the PCORnet Bariatric Study Cohort
por: Coughlin, Janelle W., et al.
Publicado: (2023)

Newer Insights into the Biochemical Physiology of the Renin–Angiotensin System: Role of Angiotensin-(1-7), Angiotensin Converting Enzyme 2, and Angiotensin-(1-12)
por: Ferrario, Carlos M., et al.
Publicado: (2009)

Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors 1 and 2
por: Clayton, Daniel, et al.
Publicado: (2015)

In Reply: Probability of Reduced Follow-up Health Care Visits for Controlled Hypertensive Patients
por: Chamberlain, Alanna M., et al.
Publicado: (2023)

New angiotensins
por: Varagic, Jasmina, et al.
Publicado: (2008)

Neuronal Angiotensin
por: Allen, A.M., et al.
Publicado: (2009)

Other Angiotensins
por: Wong, Marty K.S.
Publicado: (2016)

Web services for data warehouses: OMOP and PCORnet on i2b2
por: Klann, Jeffrey G, et al.
Publicado: (2018)

Association of New Use of Antihypertensives That Stimulate vs Inhibit Type 2 and 4 Angiotensin II Receptors With Dementia Among Medicare Beneficiaries
por: Marcum, Zachary A., et al.
Publicado: (2023)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

RENAL HYPERTENSION IN RATS IMMUNIZED AGAINST ANGIOTENSIN I AND ANGIOTENSIN II
por: Oates, Helen F., et al.
Publicado: (1974)

Distinct Molecular Effects of Angiotensin II and Angiotensin III in Rat Astrocytes
por: Clark, Michelle A., et al.
Publicado: (2013)

Angiotensin-converting enzyme 2 and new insights into the renin–angiotensin system
por: Lambert, Daniel W., et al.
Publicado: (2008)

Evaluating Foundational Data Quality in the National Patient-Centered Clinical Research Network (PCORnet®)
por: Qualls, Laura Goettinger, et al.
Publicado: (2018)

Cleaning of anthropometric data from PCORnet electronic health records using automated algorithms
por: Lin, Pi-I D, et al.
Publicado: (2022)

Is angiotensin-(3–4) (Val-Tyr), the shortest angiotensin II-derived peptide, opening new vistas on the renin–angiotensin system?
por: Dias, Juliana, et al.
Publicado: (2017)

Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Gersh, Felice L.
Publicado: (2020)

Effect of angiotensin receptor blockers and angiotensin converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in dogs with heart disease
por: Larouche‐Lebel, Éva, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jgt6nb8rpiqp4fk4agv71o7nci